Unknown

Dataset Information

0

Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.


ABSTRACT: HIV-1 CA is involved in different stages of the viral replication cycle, performing essential roles in both early (uncoating, reverse transcription, nuclear import, integration) and late events (assembly). Recent efforts have demonstrated HIV-1 CA protein as a prospective therapeutic target for the development of new antivirals. The most extensively studied CA inhibitor, PF-3450074 (PF-74, discovered by Pfizer), that targets an inter-protomer pocket within the CA hexamer. Herein we reported the design, synthesis, and biological evaluation of a series of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as HIV-1 CA inhibitors based on PF-74 scaffold. Most of the analogues demonstrated potent antiviral activities, among them, the anti-HIV-1 activity of 6a-9 (EC50 = 3.13 ?M) is particularly prominent. The SPR binding assay of selected compounds (6a-9, 6a-10, 5b) suggested direct and effective interaction with recombinant CA proteins. The mechanism of action studies also demonstrated that 6a-9 displays the effects in both the early and late stages of HIV-1 replication. To explore the potential binding mode of the here presented analogues, 6a-9 was analyzed by MD simulation to predict its binding to the active site of HIV-1 CA monomer. In conclusion, this novel series of antivirals can serve as a starting point for the development of a new generation of HIV-1 treatment regimen and highlights the potentiality of CA as a therapeutic target.

SUBMITTER: Sun L 

PROVIDER: S-EPMC7053825 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.

Sun Lin L   Huang Tianguang T   Dick Alexej A   Meuser Megan E ME   Zalloum Waleed A WA   Chen Chin-Ho CH   Ding Xiao X   Gao Ping P   Cocklin Simon S   Lee Kuo-Hsiung KH   Zhan Peng P   Liu Xinyong X  

European journal of medicinal chemistry 20200124


HIV-1 CA is involved in different stages of the viral replication cycle, performing essential roles in both early (uncoating, reverse transcription, nuclear import, integration) and late events (assembly). Recent efforts have demonstrated HIV-1 CA protein as a prospective therapeutic target for the development of new antivirals. The most extensively studied CA inhibitor, PF-3450074 (PF-74, discovered by Pfizer), that targets an inter-protomer pocket within the CA hexamer. Herein we reported the  ...[more]

Similar Datasets

| S-EPMC7034945 | biostudies-literature
| S-EPMC2960561 | biostudies-other
| S-EPMC4719915 | biostudies-literature
| S-EPMC3515254 | biostudies-literature
| S-EPMC3007252 | biostudies-literature
| S-EPMC2968371 | biostudies-literature
| S-EPMC8469956 | biostudies-literature
| S-EPMC3629624 | biostudies-literature
| S-EPMC9736318 | biostudies-literature
| S-EPMC3344657 | biostudies-literature